Hedge Fund - Bridger Management
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $11,648,200 | 6.87% | 695,000 | $16.14 |
| 2 | 2025 - Q1 (2025-03-31) | $10,682,150 | 5.31% | 695,000 | $17.86 |
| 3 | 2024 - Q4 (2024-12-31) | $15,317,800 | 8.23% | 695,000 | $18.19 |
| 4 | 2024 - Q3 (2024-09-30) | $17,677,620 | 8.84% | 981,000 | $17.50 |
| 5 | 2024 - Q2 (2024-06-30) | $15,941,250 | 8.2% | 981,000 | $15.40 |
| 6 | 2024 - Q1 (2024-03-31) | $21,165,000 | 9.54% | 1,500,000 | $12.61 |
| 7 | 2023 - Q4 (2023-12-31) | $15,660,000 | 6% | 1,500,000 | $9.34 |
| 8 | 2023 - Q3 (2023-09-30) | $15,300,000 | 5.6% | 1,500,000 | $9.31 |
| 9 | 2023 - Q2 (2023-06-30) | $11,295,000 | 3.74% | 1,500,000 | $8.11 |
| 10 | 2023 - Q1 (2023-03-31) | $13,275,000 | 4.93% | 1,500,000 | $9.89 |
| 11 | 2022 - Q4 (2022-12-31) | $13,680,000 | 5.52% | 1,500,000 | $8.73 |
| 12 | 2022 - Q3 (2022-09-30) | $12,105,000 | 0.99% | 1,500,000 | $8.84 |
| 13 | 2022 - Q2 (2022-06-30) | $11,280,000 | 2.54% | 1,500,000 | $8.71 |
| 14 | 2022 - Q1 (2022-03-31) | $14,085,000 | 2.31% | 1,500,000 | $8.35 |
| 15 | 2021 - Q4 (2021-12-31) | $12,015,000 | 1.14% | 1,500,000 | $9.03 |
| 16 | 2021 - Q3 (2021-09-30) | $14,610,000 | 1.7% | 1,500,000 | $9.36 |
| 17 | 2021 - Q2 (2021-06-30) | $14,850,000 | 1.38% | 1,500,000 | $10.58 |
| 18 | 2021 - Q1 (2021-03-31) | $17,310,000 | 1.61% | 1,500,000 | $11.47 |
| 19 | 2020 - Q4 (2020-12-31) | $14,475,000 | 1.1% | 1,500,000 | $9.58 |
| 20 | 2020 - Q3 (2020-09-30) | $13,515,000 | 1.08% | 1,500,000 | $10.58 |
| 21 | 2020 - Q2 (2020-06-30) | $18,495,000 | 1.71% | 1,500,000 | $11.31 |
| 22 | 2020 - Q1 (2020-03-31) | $13,470,000 | 1.55% | 1,500,000 | $10.25 |
| 23 | 2019 - Q4 (2019-12-31) | $14,700,000 | 1.06% | 1,500,000 | $8.93 |
| 24 | 2019 - Q3 (2019-09-30) | $10,320,000 | 0.85% | 1,500,000 | $7.66 |
| 25 | 2019 - Q2 (2019-06-30) | $13,845,000 | 1.08% | 1,500,000 | $12.06 |
| 26 | 2019 - Q1 (2019-03-31) | $23,520,000 | 1.86% | 1,500,000 | $17.63 |
| 27 | 2018 - Q4 (2018-12-31) | $23,130,000 | 1.92% | 1,500,000 | $20.50 |
| 28 | 2018 - Q3 (2018-09-30) | $32,310,000 | 1.86% | 1,500,000 | $23.22 |
| 29 | 2018 - Q2 (2018-06-30) | $36,480,000 | 1.97% | 1,500,000 | $20.39 |
| 30 | 2018 - Q1 (2018-03-31) | $12,818,000 | 0.77% | 750,000 | $19.52 |
| 31 | 2017 - Q4 (2017-12-31) | $14,213,000 | 0.93% | 750,000 | $15.04 |
| 32 | 2017 - Q3 (2017-09-30) | $13,200,000 | 0.79% | 750,000 | $22.50 |
| 33 | 2017 - Q2 (2017-06-30) | $24,915,000 | 1.42% | 750,000 | $30.95 |
| 34 | 2017 - Q1 (2017-03-31) | $58,996,000 | 3.36% | 1,838,440 | $34.13 |
| 35 | 2016 - Q4 (2016-12-31) | $0 | 0% | 0 | $39.93 |
| 36 | 2016 - Q3 (2016-09-30) | $62,495,000 | 4.21% | 1,358,287 | $52.17 |
| 37 | 2016 - Q2 (2016-06-30) | $65,529,000 | 4.23% | 1,304,572 | $53.24 |
| 38 | 2016 - Q1 (2016-03-31) | $59,320,000 | 4.1% | 1,108,574 | $58.67 |
| 39 | 2015 - Q4 (2015-12-31) | $123,524,000 | 4.08% | 1,881,837 | $61.80 |
| 40 | 2015 - Q3 (2015-09-30) | $107,519,000 | 7.33% | 1,904,346 | $64.84 |
| 41 | 2015 - Q2 (2015-06-30) | $0 | 0% | 0 | $61.69 |
| 42 | 2015 - Q1 (2015-03-31) | $25,341,000 | 1.69% | 406,756 | $58.14 |
| 43 | 2014 - Q4 (2014-12-31) | $85,402,000 | 5.37% | 1,485,000 | $55.71 |
| 44 | 2014 - Q3 (2014-09-30) | $65,218,000 | 4.44% | 1,213,362 | $52.98 |
| 45 | 2014 - Q2 (2014-06-30) | $39,446,000 | 2.77% | 752,500 | $51.11 |
| 46 | 2014 - Q1 (2014-03-31) | $53,633,000 | 3.58% | 1,015,000 | $46.22 |
| 47 | 2013 - Q4 (2013-12-31) | $36,673,000 | 2.56% | 915,000 | $39.38 |
| 48 | 2013 - Q3 (2013-09-30) | $31,735,000 | 2.27% | 840,000 | $39.01 |
| 49 | 2013 - Q2 (2013-06-30) | $28,812,000 | 2.11% | 735,000 | $38.94 |
| 50 | 2013 - Q1 (2013-03-31) | $33,331,000 | 2.3% | 840,000 | $38.59 |
The displayed share prices are average quarterly stock market prices.